#USA #Hartford #Legal Settlement #Generic Drugs #Consumer Compensation

Legal Notification on Generic Prescription Drug Settlements

On October 19, 2026, the Connecticut Office of the Attorney General announced a significant legal development regarding generic prescription drugs. Following three lawsuits initiated by the state attorneys general, a series of settlement agreements have been reached with several manufacturers of generic drugs. These settlements stem from accusations that consumers paid artificially inflated prices for certain generic medications between May 1, 2009, and December 31, 2019. As part of the resolution process, a distribution and payment plan has been proposed to compensate eligible consumers who have timely submitted claims.

Who is Eligible for Compensation?

To qualify for compensation, consumers must have purchased specific generic drugs during the stipulated period and meet the following criteria:
1. Purchases must not have been made for resale.
2. Consumers must not be senior executives, directors, or employees of any defendant.
3. They must reside in one of the relevant participating states, territories, or commonwealths, including Alabama, Arkansas, Hawaii, or Texas (specific to Apotex).

It's important to note that eligibility is based on the consumer’s current state of residence at the time of claim submission, not where the purchase was made.

How Are Benefits Calculated?

Eligible consumers will have two options for compensation:

• - Option 1: Receive an equal share from each applicable settlement.
• - Option 2: A share based on the estimated total out-of-pocket expenses incurred for the purchased drugs during the relevant period.

For consumers residing in Alabama, Arkansas, Hawaii, or Texas, they are only eligible for a fixed compensation from the Apotex settlement and do not need to choose between the options mentioned. The final compensation amount will be determined after reviewing claims, based on the number of eligible claimants and the total estimated eligible purchases per settlement.

How to Submit a Claim

Consumers wishing to submit claims must do so by the deadline of March 8, 2027. A claims form must be filled out to verify eligibility and purchase details. Claims can be submitted online at www.AGGenericdrugs.com/English/Claim_Form or downloaded and mailed to the specified address. Only claims submitted before the deadline and properly signed will qualify for the initial round of payments; however, late claims may still be considered for future distributions.

Right to Object or Opt-Out

Consumers also have the right to object to the proposed distribution and payment plan. Any written objections must be submitted by August 14, 2027. If a consumer wishes to opt out of the settlement and be excluded from the lawsuits or specific agreements, requests must also be in writing and submitted by the same date. Additional information regarding submitting objections or opting out can be found at www.AGGenericDrugs.com.

Filing the Claim Without Documentation

When submitting claims, consumers are not required to provide receipts. For those selecting Option 2, they will need to estimate their total out-of-pocket expenses. The claims administrator may later request documentation to substantiate estimated expenses, which, if unavailable, may affect the benefit payments for the eligible consumers. Consumers selecting Option 1 or those residing in Alabama, Arkansas, Hawaii, or Texas only need to demonstrate qualified purchases during the specified period.

Payment Distribution Timeline

Payments will only be distributed after the claim deadline, once all claims have been reviewed, disputes resolved, and the court has approved the plan. Eligible claimants must choose electronic payment methods such as PayPal, Venmo, or Zelle, or opt for mailed checks. Electronic payments are strongly recommended due to possible delays in mailing checks associated with cost-cutting measures.

For complete plan details, a list of involved drugs, claim forms, deadlines, opt-out instructions, and ongoing updates, consumers are encouraged to visit AGGenericDrugs.com or contact 1-866-290-0182 for more information and important documentation related to the claims and settlements.